We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Anthony Zietman MD

Anthony Zietman MD

Professor of Radiation Oncology, Harvard Medical School, Boston, Massachusetts

Dr Zietman received his undergraduate training at Oxford University in the UK and then went to medical school at the Middlesex Hospital, London University graduating in 1983. After residencies in internal medicine and clinical oncology he moved to the Massachusetts General Hospital in Boston, USA for a fellowship in radiation biology. Since joining the staff he has authored over 100 original articles and reviews on many aspects of GU cancer. His particular research interests are in the specific roles of active surveillance, brachytherapy, hormone therapy, and proton beam therapy in the management of prostate cancer. He also has a long-standing interest in the organ-sparing treatment of bladder cancer.

He is currently Shipley Professor of Radiation Oncology at Harvard Medical School and has recently finished his term as President and Chair of the American Society for Radiation Oncology (ASTRO). He is a Trustee of the American Board of Radiology and, since 2011, been editor of the International Journal of Radiation Oncology Biology Physics.   

Recent Contributions to PracticeUpdate:

  1. Adjuvant Radiotherapy Improves PFS After Radical Prostatectomy